Ana-Alicia Beltran-Bless

7PUBLICATIONS
53CO-AUTHORS
Predictive and prognostic markersDeep learningMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Data quality
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 27, 2026
A Randomized Trial Evaluating Personalized Versus Guideline-Based Well Follow-Up Strategies for Patients with Early Breast Cancer: Feasibility Outcomes.

|Apr 14, 2026
Transfer Learning and Machine Learning for Training Five-Year Survival Prognostic Models in Early Breast Cancer: Development and Validation Study.

Lisa Pilgram, Kai Yang, Ana-Alicia Beltran-Bless

|Mar 07, 2025
Augmenting Insufficiently Accruing Oncology Clinical Trials Using Generative Models: Validation Study.

Samer El Kababji, Nicholas Mitsakakis, Elizabeth Jonker

|Feb 13, 2025
Real-World Efficacy and Toxicity of Ipilimumab and Nivolumab as First-Line Treatment of Metastatic Renal Cell Carcinoma (mRCC) in a Subpopulation of Elderly and Poor Performance Status Patients.

Noa Shani Shrem, Ana-Alicia Beltran-Bless, Sunita Ghosh

|Jan 25, 2025
Diagnosis and Management of Skin Toxicities in Systemic Treatment of Genitourinary Cancers.

Deepro Chowdhury, Laura Chin, Roupen Odabashian

|Mar 27, 2024
The REthinking Clinical Trials Program Retreat 2023: Creating Partnerships to Optimize Quality Cancer Care.

Ana-Alicia Beltran-Bless, Mark Clemons, Lisa Vandermeer

Pageof 2

Frequent Collaborators

6 joint publications

Marie-France Savard

4 joint publications

Mark Clemons

4 joint publications

Khaled El Emam

3 joint publications

Gregory R Pond